The role of LHRH agonists and antagonists

Reproductive BioMedicine Online

Volumn 2, Issue 2, 2001, Pages 120-128

  Chillik, Claudio ^a   Acosta, Aníbal ^a  

^a Centro de Estudios en Ginecologia y Reproduccion Buenos Aires   (Argentina)

Author keywords

agonist; antagonist; GnRH analogues; gonadotrophins; LHRH; receptors

Indexed keywords

GONADORELIN AGONIST; GONADORELIN ANTAGONIST;

CLINICAL PROTOCOL; CONTRACEPTION; DRUG MECHANISM; ENDOMETRIOSIS; HUMAN; INFERTILITY THERAPY; ONCOLOGY; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRECOCIOUS PUBERTY; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; UTERUS MYOMA;

EID: 85006320771     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)62236-5     Document Type: Review

References (27)

1. Albano, C, Smitz, J, Camus, M, et al. Comparison of different doses of gonadotrophin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation. Fertility and Sterility 67 (1997), 917–922.
2. Albano, C, Grimbizis, G, Smitz, J, et al. The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotrophin and the gonadotrophin-releasing hormone antagonist cetrorelix. Fertility and Sterility 70 (1998), 357–359.
3. Albano, C, Felberbaum, R, Smitz, J, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)- antagonist cetrorelix and the LHRH-agonist buserelin. Human Reproduction 15 (2000), 526–531.
4. Byrd, S, Itskovitz, J, Chillik, C, et al. Flexible (FLEX) protocol for administration of human follicle stimulating hormone (FSH) with gonadotrophin-releasing hormone antagonist (GnRHant). Fertility and Sterility 57 (1992), 209–214.
5. Chillik, C, Itskovitz, J, Hahn, D, et al. Characterizing pituitary response to a gonadotrophin-releasing hormone (GnRH) antagonist in monkeys: tonic follicle-stimulating hormone/luteinizing hormone secretion versus acute GnRH challenge tests before, during and after treatment. Fertility and Sterility 48 (1987), 480–486.
6. Craft, I, Gorgy, A, Hill, J, et al. Will GnRH antagonists provide new hope for patients considered ‘difficult responders’ to GnRH agonist protocols?. Human Reproduction 14 (1999), 2959–2962.
7. Dittkoff, E, Cassidenti, D, Paulson, R, et al. The gonadotrophin-releasing hormone antagonist (Nal-Glu) acutely blocks luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. American Journal of Obstetrics and Gynecology 165 (1991), 1811–1817.
8. Felberbaum, R, Reissmann, T, Küpker, E, et al. Preserved pituitary response under ovarian stimulation with HMG and GnRH-antagonists (cetrorelix) in woman with tubal infertility. European Journal of Obstetrics, Gynecology and Reproductive Biology 61 (1995), 151–155.
9. Felberbaum, R, Germer, U, Ludwig, M, et al. Treatment of uterine fibroids with slow-release formulation of the gonadotrophin releasing hormone antagonist cetrorelix. Human Reproduction 13 (1998), 1660–1668.
10. Felberbaum, R, Diedrich, K, The use of GnRH antagonists in IVF. Shoham, Z, Howles, C, Jacobs, H, (eds.) Female infertility therapy. Current Practice, 1999, Martin Dunitz Ltd., London, UK, 203–214.
11. Felberbaum, R, Albano, C, Ludwig, M, et al. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Human Reproduction 15 (2000), 1015–1020.
12. Fiszbajn, G, Lipowicz, R, Elberger, L, et al. Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction. Journal of Assisted Reproduction and Genetics 17 (2000), 260–263.
13. Ganirelix Dose-Finding Study Group, A double-blind, randomized, dose finding study to assess the efficacy of the GnRH-antagonist Ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian hyperstimulation with recombinant follicle stimulating hormone. Human Reproduction 13 (1998), 3023–3031.
14. Hernandez, ER, Embryo implantation and GnRH antagonists. Embryo implantation: the Rubicon for GnRH antagonists. Human Reproduction 15 (2000), 1211–1216.
15. Knobil, E, The neuroendocrine control of the menstrual cycle. Recent Progress in Hormone Research, 35, 1980, 53.
16. Kol, S, Lightman, A, Hillensjo, T, et al. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Human Reproduction 14 (1999), 2242–2248.
17. Lahat, E, Raziel, A, Friedler, S, et al. Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy. Human Reproduction 14 (1999), 2656–2660.
18. Ludwig, M, Felberbaum, R, Küpker, W, Diedrich, K, The development and applications of LHRH antagonists. Reproductive Medicine Review 8 (2000), 41–56.
19. Mehta, R, Anand Kumar, T, Can GnRH agonists act directly on the ovary and contribute to cyst formation?. Human Reproduction 15 (1999), 505–507.
20. Oberyé, J, Mannaerts, B, Huisman, J, Timmer, C, Local tolerance, pharmacokinetics, and dynamics of ganirelix (Orgalutran) administration by Medi-Jector compared to conventional needle injections. Human Reproduction 15 (2000), 245–249.
21. Olivennes, F, Alvarez, S, Bouchard, P, et al. The use of a GnRH antagonist (cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Human Reproduction 13 (1998), 2411–2414.
22. Ortmann, O, Diedrich, K, Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues. Human Reproduction 14:supplement 1 (1999), 194–206.
23. Raga, F, Casan, E, Kruessel, J, et al. The role of gonadotrophin releasing hormone in murine preimplantation embryonic development. Endocrinology 140 (1999), 3705–3712.
24. Rongiéres-Bertrand, C, Olivennes, F, Riguini, C, et al. Revival of the natural cycle in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (cetrorelix): a pilot study with minimal stimulation. Human Reproduction 14 (1999), 683–688.
25. Schally, A, LH-RH analogues: I. Their impact on reproductive medicine. Gynecologic Endocrinology 13 (1999), 401–409.
26. Tahara, M, Matsuoka, T, Yokoi, T, et al. Treatment of endometriosis with a decreasing dosage of a gonadotrophin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (‘draw-back’ therapy). Fertility and Sterility 73 (2000), 799–804.
27. Weissman, A, Shoham, Z, GnRH and its agonistic analogues: basic knowledge. Shoham, Z, Howles, C, Jacobs, H, (eds.) Female infertility therapy. Current Practice, 1999, Martin Dunitz Ltd., London, UK, 157–166.